Detalhe da pesquisa
1.
A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer.
Cell
; 174(2): 422-432.e13, 2018 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29909987
2.
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles.
Cell
; 171(6): 1437-1452.e17, 2017 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29195078
3.
Binding of TMPRSS2-ERG to BAF Chromatin Remodeling Complexes Mediates Prostate Oncogenesis.
Mol Cell
; 71(4): 554-566.e7, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30078722
4.
Implementation of a prostate cancer-specific targeted sequencing panel for credentialing of patient-derived cell lines and genomic characterization of patient samples.
Prostate
; 82(5): 584-597, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35084050
5.
Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma.
Br J Cancer
; 119(6): 707-712, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30220708
6.
Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy.
Br J Cancer
; 115(1): 12-9, 2016 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27351382
7.
Beyond immune checkpoint blockade: new approaches to targeting host-tumor interactions in prostate cancer: report from the 2014 Coffey-Holden prostate cancer academy meeting.
Prostate
; 75(4): 337-47, 2015 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25358693
8.
Unpacking circulating tumor DNA lends insight into prostate cancer biology and the clonal dynamics of metastasis.
Cancer Cell
; 40(10): 1086-1088, 2022 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179684
9.
Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation.
Nat Genet
; 54(9): 1364-1375, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071171
10.
A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancer.
Cell Rep
; 38(8): 110417, 2022 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196489
11.
Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer.
Nat Commun
; 12(1): 1979, 2021 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785741
12.
Prostate cancer reactivates developmental epigenomic programs during metastatic progression.
Nat Genet
; 52(8): 790-799, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32690948
13.
Mutational processes shape the landscape of TP53 mutations in human cancer.
Nat Genet
; 50(10): 1381-1387, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224644
14.
DNA replication and progression through S phase.
Oncogene
; 24(17): 2827-43, 2005 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-15838518
15.
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis.
Nat Genet
; 47(11): 1346-51, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26457646
16.
Degradation of Cdt1 during S phase is Skp2-independent and is required for efficient progression of mammalian cells through S phase.
J Biol Chem
; 280(24): 23416-23, 2005 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-15855168
17.
Recruitment of ORC or CDC6 to DNA is sufficient to create an artificial origin of replication in mammalian cells.
Genes Dev
; 19(23): 2827-36, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16322558